Share
Export Citation
APA
MLA
Chicago
Harvard
Vancouver
BIBTEX
RIS
Universitas Hasanuddin
Research output:Contribution to journal›Article›peer-review
microRNA-221 and tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study
Amiruddin A.
Annals of Medicine and Surgery
Published: 2022Citations: 23
Abstract
miR-221 expression was higher in tamoxifen-resistant BC cases. miR-221 is a potential biomarker of tamoxifen resistance.
Access to Document
10.1016/j.amsu.2021.103092Other files and links
- Link to publication in Scopus
- Open Access Version Available
Fingerprint
TamoxifenSciences
MedicineSciences
Breast cancerSciences
Lymphovascular invasionSciences
OncologySciences
Internal medicineSciences
Estrogen receptorSciences
Adjuvant therapySciences
CancerSciences
EstrogenSciences
BiomarkerSciences
microRNASciences
Endocrine systemSciences
Cancer researchSciences
MetastasisSciences
HormoneSciences
BiologySciences
GeneSciences
BiochemistrySciences